WuXi AppTec Investor
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve the productivity of advancing healthcare products through cost-effective and efficient solutions,With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,900 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated".
Invests into
Technology:
Biotechnology, Health Care, Medical Device, Outsourcing, Pharmaceutical
Industry:
End-to-end Drug Development
Headquarters:
Shanghai, Shanghai, China
Founded Date:
2000-12-01
Employees Number:
10001+
Funding Status:
IPO
Number Of Exits:
6
Acquisitions Number:
6
Investors Number:
5
Total Funding:
1593470000
Estimated Revenue:
$100M to $500M
Last Funding Date:
2016-03-06
Last Funding Type:
Debt Financing
Register and Claim Ownership